Drug Profile
Research programme: antibody-producing encapsulated cell therapies - PharmaCyte Biotech
Alternative Names: Live-cell antibody-producing therapeutics - PharmaCyte BiotechLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nuvilex
- Developer PharmaCyte Biotech
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Autoimmune disorders; Cancer; Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (Parenteral, Implant)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral, Implant)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in USA (Parenteral, Implant)